ERAS-007

· Erasca, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ERAS-007, covering 2024-08-27 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies [Phase 1, Phase 2]